Abstract: A spinner (100) adapted to spin on a surface comprising: a spinning mechanism (300) activated by a string (142); a structure encapsulating the spinning mechanism (300); a plurality of tentacles (110) having two ends, wherein each tentacle (110) is in connected to the structure on one end and terminated with a connector on the free end; a flywheel (122) having a tip (121), wherein the flywheel (122) is connected to the spinning mechanism (300) from the opposite side of the tip (121); and wherein upon pulling the string (142) the spinner (100) spins, wherein the tip (121) is in contact with the surface and the plurality of tentacles (110) are slightly elevated above the surface while the spinner (100) spins.

Abstract: A spinner (100) adapted to spin on a surface comprising: a spinning mechanism (300) activated by a string (142); a structure encapsulating the spinning mechanism (300); a plurality of tentacles (110) having two ends, wherein each tentacle (110) is in connected to the structure on one end and terminated with a connector on the free end; a flywheel (122) having a tip (121), wherein the flywheel (122) is connected to the spinning mechanism (300) from the opposite side of the tip (121); and wherein upon pulling the string (142) the spinner (100) spins, wherein the tip (121) is in contact with the surface and the plurality of tentacles (110) are slightly elevated above the surface while the spinner (100) spins.

Abstract: A launcher (300) for pawns (666) comprising: a chamber comprising a base (110) and a muzzle situated opposite to each other, wherein the chamber is configured to be loaded with the pawn (666), via the muzzle; a magnet secured to the base (110); a bolt adapted to slide within the chamber to a loading position; a spring confined between the bolt and the base (110), wherein the spring is adapted to be squeezed; wherein by loading the pawn (666) into the chamber the bolt slide against the spring thereby squeeze the spring to the load position, wherein the bolt is configured to be retained in the load position, and wherein external impact break the magnetic field thus release the spring for driving the bolt toward the muzzle.

Abstract: A launcher (300) for pawns (666) comprising: a chamber comprising a base (110) and a muzzle situated opposite to each other, wherein the chamber is configured to be loaded with the pawn (666), via the muzzle; a magnet secured to the base (110); a bolt adapted to slide within the chamber to a loading position; a spring confined between the bolt and the base (110), wherein the spring is adapted to be squeezed; wherein by loading the pawn (666) into the chamber the bolt slide against the spring thereby squeeze the spring to the load position, wherein the bolt is configured to be retained in the load position, and wherein external impact break the magnetic field thus release the spring for driving the bolt toward the muzzle .

Abstract: The present invention relates to a proteolytic extract obtained from bromelain for the treatment of connective tissue diseases. In particular, the present invention relates to a pharmaceutical composition comprising a proteolytic extract obtained from bromelain for the treatment of diseases such as Dupuytren's disease and Peyronie's disease.

Abstract: The present invention relates to a proteolytic extract obtained from bromelain for the treatment of connective tissue diseases. In particular, the present invention relates to a pharmaceutical composition comprising a proteolytic extract obtained from bromelain for the treatment of diseases such as Dupuytren's disease and Peyronie's disease.

Abstract: The present invention relates to a proteolytic extract obtained from bromelain for the treatment of connective tissue diseases. In particular, the present invention relates to a pharmaceutical composition that includes proteolytic extract obtained from bromelain for the treatment of diseases such as Dupuytren's disease and Peyronie's disease.

Abstract: The present invention relates to a proteolytic extract obtained from bromelain for the treatment of connective tissue diseases. In particular, the present invention relates to a pharmaceutical composition that includes proteolytic extract obtained from bromelain for the treatment of diseases such as Dupuytren's disease and Peyronie's disease.